Entyvio 300 mg/5mL
vedolizumab · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Takeda Pharmaceuticals America, Inc.
No Recall History
Plain English
Entyvio is a injection, powder, lyophilized, for solution containing vedolizumab at 300 mg/5mL, taken intravenous. Manufactured by Takeda Pharmaceuticals America, Inc..
Key Facts
- Brand Name
- Entyvio
- Generic Name
- vedolizumab
- NDC Code (Product)
64764-300- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Strength
- 300 mg/5mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125476
- Drug Class
- Integrin Receptor Antagonist [EPC]
- Marketing Start
- 05/20/2014
Recall History
No Recall HistoryFrequently Asked Questions
What is Entyvio used for?
Entyvio contains vedolizumab. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is Entyvio a controlled substance?
Entyvio is not classified as a controlled substance by the DEA.
What is the generic name for Entyvio?
The generic name for Entyvio is vedolizumab. There are 2 other brand versions of vedolizumab.
What is the NDC code for Entyvio 300 mg/5mL?
The NDC (National Drug Code) for Entyvio 300 mg/5mL is 64764-300, listed by Takeda Pharmaceuticals America, Inc..